Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duac once-daily gel versus clindamycin gel twice daily for mild to moderate acne vulgaris
2015-004909-16Phase 3
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in acne vulgaris comparing Duac once daily with Clindamycin gel twice daily (2 arms). Primary endpoint: Absolute change in inflammatory and noninflammatory (total) lesion counts from baseline to Week 12.
02
Drugs
clindamycin phosphate + benzoyl peroxideclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-004909-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004909-16.